Haoliang Yuan
China Pharmaceutical University(CN)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Cancer therapeutics and mechanisms, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Synthesis and biological activity
Most-Cited Works
- → Discovery of 4-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrazole-3-carboxamide (FN-1501), an FLT3- and CDK-Kinase Inhibitor with Potentially High Efficiency against Acute Myelocytic Leukemia(2018)120 cited
- → The STING antagonist H‐151 ameliorates psoriasis via suppression of STING/NF‐κB‐mediated inflammation(2021)98 cited
- → USP7: Target Validation and Drug Discovery for Cancer Therapy(2018)95 cited
- → Syntheses, Biological Evaluations, and Mechanistic Studies of Benzo[c][1,2,5]oxadiazole Derivatives as Potent PD-L1 Inhibitors with In Vivo Antitumor Activity(2021)58 cited
- → An Integrated Virtual Screening Approach for VEGFR-2 Inhibitors(2013)54 cited
- → Developing a Novel Gold(III) Agent to Treat Glioma Based on the Unique Properties of Apoferritin Nanoparticles: Inducing Lethal Autophagy and Apoptosis(2020)49 cited
- → Pharmacophore modeling and virtual screening studies to identify new c-Met inhibitors(2011)44 cited
- → Discovery, optimization and biological evaluation for novel c-Met kinase inhibitors(2017)44 cited
- → A SNP of bacterial blc disturbs gut lysophospholipid homeostasis and induces inflammation through epithelial barrier disruption(2020)38 cited
- → Synthesis and anti-inflammatory activity of saponin derivatives of δ-oleanolic acid(2020)38 cited